271 related articles for article (PubMed ID: 20959556)
1. Loss of suppression of tumorigenicity 2 (ST2) gene reverses sepsis-induced inhibition of lung host defense in mice.
Hoogerwerf JJ; Leendertse M; Wieland CW; de Vos AF; de Boer JD; Florquin S; van der Poll T
Am J Respir Crit Care Med; 2011 Apr; 183(7):932-40. PubMed ID: 20959556
[TBL] [Abstract][Full Text] [Related]
2. IL-27 controls sepsis-induced impairment of lung antibacterial host defence.
Cao J; Xu F; Lin S; Song Z; Zhang L; Luo P; Xu H; Li D; Zheng K; Ren G; Yin Y
Thorax; 2014 Oct; 69(10):926-37. PubMed ID: 25074706
[TBL] [Abstract][Full Text] [Related]
3. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.
Chen GH; Reddy RC; Newstead MW; Tateda K; Kyasapura BL; Standiford TJ
J Immunol; 2000 Dec; 165(11):6496-503. PubMed ID: 11086090
[TBL] [Abstract][Full Text] [Related]
4. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ
J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression.
Song Z; Zhang J; Zhang X; Li D; Wang H; Xu X; Xu W; Yin Y; Cao J
J Infect Dis; 2015 May; 211(10):1616-27. PubMed ID: 25489003
[TBL] [Abstract][Full Text] [Related]
6. A disturbed interaction with accessory cells upon opportunistic infection with Pseudomonas aeruginosa contributes to an impaired IFN-γ production of NK cells in the lung during sepsis-induced immunosuppression.
Pastille E; Pohlmann S; Wirsdörfer F; Reib A; Flohé SB
Innate Immun; 2015 Feb; 21(2):115-26. PubMed ID: 24406749
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction.
Pène F; Zuber B; Courtine E; Rousseau C; Ouaaz F; Toubiana J; Tazi A; Mira JP; Chiche JD
J Immunol; 2008 Dec; 181(12):8513-20. PubMed ID: 19050269
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
Pène F; Grimaldi D; Zuber B; Sauneuf B; Rousseau C; El Hachem C; Martin C; Belaïdouni N; Balloy V; Mira JP; Chiche JD
J Infect Dis; 2012 Sep; 206(6):932-42. PubMed ID: 22782952
[TBL] [Abstract][Full Text] [Related]
9. Ethyl pyruvate reverses development of Pseudomonas aeruginosa pneumonia during sepsis-induced immunosuppression.
Chen W; Lian J; Ye JJ; Mo QF; Qin J; Hong GL; Chen LW; Zhi SC; Zhao GJ; Lu ZQ
Int Immunopharmacol; 2017 Nov; 52():61-69. PubMed ID: 28863323
[TBL] [Abstract][Full Text] [Related]
10. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
Huang X; Du W; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
[TBL] [Abstract][Full Text] [Related]
11. An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia.
Hajjar AM; Harowicz H; Liggitt HD; Fink PJ; Wilson CB; Skerrett SJ
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):470-5. PubMed ID: 16100080
[TBL] [Abstract][Full Text] [Related]
12. Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression.
Murphey ED; Sherwood ER
Shock; 2006 Oct; 26(4):417-24. PubMed ID: 16980891
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
[TBL] [Abstract][Full Text] [Related]
14. Systematic investigation on the turning point of over-inflammation to immunosuppression in CLP mice model and their characteristics.
Deng D; Li X; Liu C; Zhai Z; Li B; Kuang M; Li P; Shang S; Song Y; Cen Y; Qin R; Lu Y; Zhao Y; Cheng H; Zheng J; Zhou H
Int Immunopharmacol; 2017 Jan; 42():49-58. PubMed ID: 27875749
[TBL] [Abstract][Full Text] [Related]
15. Lipid-rich enteral nutrition improves the defense against an opportunistic infection during polymicrobial sepsis.
de Haan JJ; Pastille E; Wirsdörfer F; Lubbers T; Greve JW; Zhang Y; Buurman WA; Flohé SB
Shock; 2014 Feb; 41(2):109-14. PubMed ID: 24434414
[TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin 10.
Reddy RC; Chen GH; Newstead MW; Moore T; Zeng X; Tateda K; Standiford TJ
Infect Immun; 2001 Mar; 69(3):1394-401. PubMed ID: 11179304
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary and Nonpulmonary Sepsis Differentially Modulate Lung Immunity toward Secondary Bacterial Pneumonia: A Critical Role for Alveolar Macrophages.
Llitjos JF; Auffray C; Péju E; Hamou ZA; Rousseau C; Durand A; Martin C; Mira JP; Burgel PR; Chiche JD; Ladjemi MZ; Lucas B; Pène F
Am J Respir Cell Mol Biol; 2023 Jun; 68(6):689-701. PubMed ID: 36883953
[TBL] [Abstract][Full Text] [Related]
18. Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression.
Murphey ED; Lin CY; McGuire RW; Toliver-Kinsky T; Herndon DN; Sherwood ER
Shock; 2004 May; 21(5):415-25. PubMed ID: 15087817
[TBL] [Abstract][Full Text] [Related]
19. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
[TBL] [Abstract][Full Text] [Related]
20. Mice Survival and Plasmatic Cytokine Secretion in a "Two Hit" Model of Sepsis Depend on Intratracheal Pseudomonas Aeruginosa Bacterial Load.
Restagno D; Venet F; Paquet C; Freyburger L; Allaouchiche B; Monneret G; Bonnet JM; Louzier V
PLoS One; 2016; 11(8):e0162109. PubMed ID: 27574993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
